PREVALENCE OF CARDIOVASCULAR DISEASE IN PATIENTS WITH METABOLIC SYNDROME IN THE IBERICAN STUDY

Objective: The general objectives of IBERICAN are to determine the prevalence and incidence of cardiovascular risk factors in Spain, as well as cardiovascular events. The objective of the present work is to analyze the presence of cardiovascular disease in patients with metabolic syndrome (MS) Design and method: IBERICAN is a longitudinal, observational, and multicenter study in which patients from 18 to 85 years of age are included in Primary Care consultations in Spain, until a sample of 7,000 patients is collected, which will be followed for at least 5 years. The basal characteristics of the cut are presented (n = 6.007). The Metabolic Syndrome (MS) was defined according to the criteria of the International Diabetes Federation Task Force. Patients were classified in secondary prevention when they presented ischemic heart disease, heart failure, stroke or peripheral arterial disease. Results: The average age of the subjects included was 57.4 ± 15.5 years, and 54.5% were women. 38.2% met MS criteria. Patients with MS were older (62.4 ± 12.9 years vs. 54.2 ± 16.1 years, p < 0.001) and with a lower percentage of women (50.7% vs. 56.8%, p < 0.001). The prevalence of cardiovascular disease was higher in patients with MS (21.8% vs 13.1%, p < 0.001). Ischemic heart disease (9.8% vs 5.3%, p < 0.001), peripheral arterial disease (6.8% vs 3.7%, p < 0.001) and heart failure (5.4% vs 1.8%, p < 0.001) were more frequent in patients with MS. Stroke (4.7% vs. 3.2%, p = 0.267) and retinopathy (0.7% vs. 0.3%, p = 0.281) did not reach statistically significant differences Conclusions: cardiovascular disease prevalence is higher in patients with MS, which gives them an extra cardiovascular risk